February 11, 2007

Unhelpful

What the Democratic Congress has to look forward to as it starts the cleanup:

Last summer, the Finance Committee was looking into the role of falsified clinical data in the FDA approval of a drug. After Grassley accused the Justice Department of working with HHS to obstruct that investigation, finance committee staff were blocked from interviewing FDA investigators by the Justice Department. Grassley took the extraordinary step of going directly to FDA offices to speak with FDA personnel, but was still not allowed access to them.

In a December hearing of the Judiciary Committee, just before Congress changed hands, Grassley and the panel's then-chairman, Specter, uncovered further evidence of Justice Department collusion in efforts to thwart congressional inquiry and intimidate whistleblowers. This involved the unheard-of step of subpoenaing confidential discussions between a whistleblower and congressional staff.

Posted by binky at February 11, 2007 02:14 PM | TrackBack | Posted to Corruption | Politics


Comments
Post a comment









Remember personal info?